Filings

Finds words inside filing documents. Searching NUTRA PHARMA CORP's filings · 17 documents indexed.

16 documents · 41 matches

NPHC NUTRA PHARMA CORP 10-K 2026-05-20

Item 9A. Controls and Procedures
material weaknesses. These identified material weaknesses included (i) an insufficient accounting staff; (ii) inadequate segregation of duties; (iii) limited checks
8 matches in this document
NPHC NUTRA PHARMA CORP 10-K 2026-02-17

Item 9A. Controls and Procedures
material weaknesses. These identified material weaknesses included (i) an insufficient accounting staff; (ii) inadequate segregation of duties; (iii) limited checks
8 matches in this document
NPHC NUTRA PHARMA CORP 10-K 2025-11-24

Item 9A. Controls and Procedures
material weaknesses. These identified material weaknesses included (i) an insufficient accounting staff; (ii) inadequate segregation of duties; (iii) limited checks
8 matches in this document
NPHC NUTRA PHARMA CORP 10-K 2025-09-03

Item 9A. Controls and Procedures
material weaknesses. These identified material weaknesses included (i) an insufficient accounting staff; (ii) inadequate segregation of duties; (iii) limited checks
5 matches in this document
NPHC NUTRA PHARMA CORP 10-Q 2026-08-19

Item 4. Controls and Procedures
material weaknesses in internal control over financial reporting discussed in Section 9A of our annual report on Form 10–K, our disclosure
1 match in this document
NPHC NUTRA PHARMA CORP 10-Q 2026-05-29

Item 4. Controls and Procedures
material weaknesses in internal control over financial reporting discussed in Section 9A of our annual report on Form 10–K, our disclosure
1 match in this document
NPHC NUTRA PHARMA CORP 10-Q 2026-04-06

Item 4. Controls and Procedures
material weaknesses in internal control over financial reporting discussed in Section 9A of our annual report on Form 10–K, our disclosure
1 match in this document
NPHC NUTRA PHARMA CORP 10-Q 2026-03-25

Item 4. Controls and Procedures
material weaknesses in internal control over financial reporting discussed in Section 9A of our annual report on Form 10–K, our disclosure
1 match in this document
NPHC NUTRA PHARMA CORP 10-Q 2026-03-11

Item 4. Controls and Procedures
material weaknesses in internal control over financial reporting discussed in Section 9A of our annual report on Form 10–K, our disclosure
1 match in this document
NPHC NUTRA PHARMA CORP 10-Q 2026-01-02

Item 4. Controls and Procedures
material weaknesses in internal control over financial reporting discussed in Section 9A of our annual report on Form 10–K, our disclosure
1 match in this document
NPHC NUTRA PHARMA CORP 10-Q 2025-12-23

Item 4. Controls and Procedures
material weaknesses in internal control over financial reporting discussed in Section 9A of our annual report on Form 10–K, our disclosure
1 match in this document
NPHC NUTRA PHARMA CORP 10-Q 2025-12-17

Item 4. Controls and Procedures
material weaknesses in internal control over financial reporting discussed in Section 9A of our annual report on Form 10–K, our disclosure
1 match in this document
NPHC NUTRA PHARMA CORP 10-Q 2025-10-28

Item 4. Controls and Procedures
material weaknesses in internal control over financial reporting discussed in Section 9A of our annual report on Form 10–K, our disclosure
1 match in this document
NPHC NUTRA PHARMA CORP 10-Q 2025-10-23

Item 4. Controls and Procedures
material weaknesses in internal control over financial reporting discussed in Section 9A of our annual report on Form 10–K, our disclosure
1 match in this document
NPHC NUTRA PHARMA CORP 10-Q 2025-10-16

Item 4. Controls and Procedures
material weaknesses in internal control over financial reporting discussed in Section 9A of our annual report on Form 10–K, our disclosure
1 match in this document
NPHC NUTRA PHARMA CORP 8-K 2025-09-03

Item 4.01. Changes in Registrant’s Certifying Accountant
Item 304(a)(1)(v) of Regulation S-K), except for the following material weaknesses in the Company’s internal control over financial reporting:
1 match in this document

Page 1 of 1 · 16 documents